Dose-Fractionated Radioimmunotherapy in Non-Hodgkin's Lymphoma Using DOTA-Conjugated, 90Y-Radiolabeled, Humanized Anti-CD22 Monoclonal Antibody, Epratuzumab.
Author
Publishing year
2005
Language
English
Pages
5215-5222
Publication/Series
Clinical Cancer Research
Volume
11
Issue
14
Links
Document type
Journal article
Publisher
American Association for Cancer Research
Topic
- Cancer and Oncology
Status
Published
ISBN/ISSN/Other
- ISSN: 1078-0432